Atlas Trials

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Clinical trial NCT01088737 · UNKNOWN

Trial details

NCT number
NCT01088737
Sponsor
Medical University of Graz
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Lentigo Maligna
Start date
2011-01-01
Primary completion
2021-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.